Experts flag UK-India FTA over patent terms, access to drugs

Concerns are mounting in India over the UK-India Free Trade Agreement's potential impact on access to affordable medicines. Experts fear the deal may weaken compulsory licensing norms, a crucial safeguard allowing generic drug production during public health emergencies.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/p1y7eBh
via IFTTT